CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy

The expanding clinical application of CDK4- and CDK6-inhibiting drugs in the managements of breast cancer has raised a great interest in testing these drugs in other neoplasms. The potential of combining these drugs with other therapeutic approaches seems to be an interesting work-ground to explore....

Descripción completa

Detalles Bibliográficos
Autores principales: Nardone, Valerio, Barbarino, Marcella, Angrisani, Antonio, Correale, Pierpaolo, Pastina, Pierpaolo, Cappabianca, Salvatore, Reginelli, Alfonso, Mutti, Luciano, Miracco, Clelia, Giannicola, Rocco, Giordano, Antonio, Pirtoli, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395054/
https://www.ncbi.nlm.nih.gov/pubmed/34445095
http://dx.doi.org/10.3390/ijms22168391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395054/
https://www.ncbi.nlm.nih.gov/pubmed/34445095
http://dx.doi.org/10.3390/ijms22168391

Ejemplares similares